3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
October 31, 2013 — Abbott announced it plans to initiate a randomized, controlled trial in the United States to evaluate ...
October 31, 2013
October 29, 2013 — Biotronik Japan announced enrollment of the first patient in the Bioflow-IV study, which aims to ...
October 29, 2013
This animation, provided by Abbott Vascular, demonstrates how the U.S. Food and Drug Administration (FDA)-cleared ...
October 25, 2013
October 25, 2013 — The U.S. Food and Drug Administration (FDA) has granted market clearance for the MitraClip, the first ...
October 25, 2013October 23, 2013 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to ...
October 23, 2013
September 20, 2013— The Mount Sinai Medical Center is participating in the nationwide Absorb III clinical trial testing ...
September 20, 2013Feature | Dave Fornell
There is no shortage of debate among interventional cardiologists over whether vascular closure devices should be used ...
September 13, 2013
Feature | Patrick Antoun, M.D., and Jeffrey A. Breall, M.D., Ph.D.
Vascular closure devices (VCD) were first introduced in the early 1990s with a goal to achieve quick hemostasis, thus ...
September 13, 2013September 12, 2013 — Abbott promised preliminary results from a study presented at the ESC Congress 2013, suggesting ...
September 12, 2013
August 2, 2013 — Abbott announced results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay. The study ...
August 02, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now